Oppenheimer's One Buy Vs. One Sell Idea From Each SMID Sector
Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
Sweetgreen, Tesla, Digital Realty Trust And A Health Care Stock On CNBC's 'Final Trades'
AbbVie to Buy Aliada Therapeutics for $1.4B in Cash
About 75% of Companies That Reported Earnings This Week Delivered EPS Wins-Earnings Scorecard
Forecasting The Future: 11 Analyst Projections For AbbVie
AbbVie Analyst Ratings
IDEAYA Reports Phase 1 Expansion Data for IDE397
Check Out What Whales Are Doing With ABBV
3 Health Care Stocks Moving In Thursday's Intraday Session
Peering Into Insmed's Recent Short Interest
UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday
Market-Moving News for October 24th
Viking Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results.
Viking Therapeutics GAAP EPS of -$0.22 Beats by $0.03
$100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
Incyte Analyst Ratings
Here Are the Major Earnings After the Close Today
An Overview of Viking Therapeutics's Earnings
Market Whales and Their Recent Bets on VKTX Options